title: Rituximab therapy for cytomegalovirus-associated auto-immune hemolytic anemia in a liver-transplant recipient.
authors.forename: Joëlle
authors.initials: J
authors.lastname: Guitard
authors.forename: Nassim
authors.initials: N
authors.lastname: Kamar
authors.forename: Leila
authors.initials: L
authors.lastname: Ouezzani
authors.forename: Lionel
authors.initials: L
authors.lastname: Rostaing
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003586:Cytomegalovirus Infections / Q000150:complications*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab